PEG vs PHAT · P/E 18, rev $10.29B vs rev $55.3M
Public Service Enterprise Group Inc (PEG) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the PEG and PHAT stock pages for the full models.
Not investment advice.